Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TSRO | TESARO, Inc. | -1.07% | 73.69 | 14.4% | $580.10m | |
| AMGN | Amgen Inc. | -2.76% | 192.07 | 1.2% | $565.07m | |
| GILD | Gilead Sciences, Inc. | -2.64% | 65.57 | 0.9% | $530.36m | |
| CELG | Celgene Corporation | -2.21% | 68.20 | 1.2% | $520.26m | |
| BIIB | Biogen Inc. | -1.75% | 314.55 | 1.3% | $359.40m | |
| ILMN | Illumina, Inc. | -2.44% | 326.46 | 3.5% | $350.15m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.70% | 381.17 | 2.6% | $273.12m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.94% | 170.06 | 1.9% | $226.47m | |
| A | Agilent Technologies, Inc. | -2.49% | 69.37 | 1.5% | $225.54m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.67% | 109.43 | 2.0% | $146.61m | |
| INCY | Incyte Corporation | -1.55% | 66.25 | 2.5% | $97.76m | |
| EXAS | Exact Sciences Corporation | 0.68% | 68.31 | 25.3% | $93.39m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.05% | 119.52 | 15.4% | $90.77m | |
| NKTR | Nektar Therapeutics | -3.92% | 36.51 | 5.5% | $84.08m | |
| SGEN | Seattle Genetics, Inc. | -0.85% | 60.48 | 6.6% | $81.91m |
Company Profile
CRISPR Therapeutics AG engages in the development and commercializtion of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, and Shaun Patrick Foy in 2014 and is headquartered in Zug, Switzerland.